Geneos Wealth Management’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696 Hold
5
﹤0.01% 2455
2026
Q1
$666 Hold
5
﹤0.01% 2445
2025
Q4
$867 Sell
5
-80
-94% -$14.6K ﹤0.01% 2420
2025
Q3
$17.4K Sell
85
-9
-10% -$1.9K ﹤0.01% 1776
2025
Q2
$18.6K Buy
94
+6
+7% +$1.09K ﹤0.01% 2062
2025
Q1
$15.2K Sell
88
-221
-72% -$46K ﹤0.01% 2069
2024
Q4
$83.5K Buy
309
+222
+255% +$63.2K ﹤0.01% 1125
2024
Q3
$24.5K Buy
+87
New +$22.1K ﹤0.01% 1489
2017
Q4
Sell
-350
Closed -$14K 2197
2017
Q3
$14K Hold
350
﹤0.01% 1457
2017
Q2
$16K Hold
350
﹤0.01% 1362
2017
Q1
$18K Hold
350
﹤0.01% 1271
2016
Q4
$18K Buy
+350
New +$18.7K ﹤0.01% 1232

Other funds holding MANH

Geneos Wealth Management's MANH Position: Q2 2026 in Review

Geneos Wealth Management held its Manhattan Associates (MANH) position steady in Q2 2026 at 5 shares worth $696. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Geneos Wealth Management first reported a position in MANH in Q4 2016 and has held it in 12 quarters since. The position peaked at $83.5K in Q4 2024. 504 funds tracked by Wall St. Rank hold MANH as of Q2 2026.

  • Geneos Wealth Management held 5 shares of Manhattan Associates worth $696 as of Q2 2026.
  • Geneos Wealth Management left its Manhattan Associates share count unchanged in Q2 2026.
  • Manhattan Associates made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2455 holding.
  • Geneos Wealth Management first reported a position in Manhattan Associates in Q4 2016 and has held it in 12 quarters since.
  • Geneos Wealth Management's Manhattan Associates position peaked at $83.5K in Q4 2024.
  • 504 funds tracked by Wall St. Rank held Manhattan Associates as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.